Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsPAR-25-069

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

National Institutes of Health opportunity PAR-25-069

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-25-069Grants.gov
Related Grants
Health● Open
In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
Varies
01 Oct 2026(0d)
Health● Open
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
Varies
29 Sep 2027(362d)
Health● Open
NIH Research Project Grant (Parent R01 Clinical Trial Required)
Varies
07 Jan 2028(462d)
HealthUpcoming
Clinical Data Ecosystem for Genomics (CDEG)
Varies
Funding Amount
Varies
USD
Application Deadline
7 January 2027
97 days remaining
Opens: 18 Nov 2024
Apply Now
Programme Details
Programme Code
PAR-25-069